Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer crawled date : 2021 - 11 - 03 save search
NexImmune to Present at The Society for Immunotherapy of Cancer 36th Anniversary Annual Meeting
Published: 2021-11-03 (Crawled : 19:00) - biospace.com/
NEXI | $3.59 -1.51% -1.53% 6.8K
|
|
| O: -1.46%
H: 2.26%
C: 0.17%
immunotherapy therapy cancer
With Market Size Valued at $2.8 Billion by 2026, it`s a Healthy Outlook for the Global Cancer Cachexia Market
Published: 2021-11-03 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 1.95%
H: 0.06%
C: 0.06%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 2.72%
H: 0.0%
C: 0.0%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -0.14%
H: 3.12%
C: 2.55%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 1.52%
H: 0.19%
C: -0.19%
cancer
New Publication Reinforces Clinical Utility of Afirma Genomic Sequencing Classifier in Thyroid Cancer Diagnosis
Published: 2021-11-03 (Crawled : 13:00) - biospace.com/
VCYT | News | $19.82 -0.15% -0.15% 560K
|
Health Technology
|
| O: 2.48%
H: 2.57%
C: 2.4%
NSTG M | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: -3.2%
H: 5.64%
C: 5.05%
genomic cancer diagnostic
Global Metastatic Cancer Treatment Market Size Is Forecasted To Reach $111.16 Million By 2027
Published: 2021-11-03 (Crawled : 13:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 1.95%
H: 0.06%
C: 0.06%
MRK | $126.88 -0.05% -0.13% 7.5M
|
Health Technology
|
| O: 0.7%
H: 0.0%
C: 0.0%
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 1.4%
H: 0.49%
C: -1.84%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: -4.63%
H: 8.31%
C: 8.31%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 1.52%
H: 0.19%
C: -0.19%
ARAY | $2.22 2.3% 2.25% 410K
|
Health Technology
|
| O: 3.45%
H: 3.34%
C: 2.41%
treatment cancer
Alkermes to Present Data on Nemvaleukin Alfa at the Society for Immunotherapy of Cancer's (SITC) 36th Annual Meeting
Published: 2021-11-03 (Crawled : 12:15) - biospace.com/
ALKS | $24.26 0.79% 0.78% 1.2M
|
Health Technology
|
| O: -2.41%
H: 3.58%
C: 3.48%
immunotherapy therapy cancer nemvaleukin
Oncolytics Biotech® Doses First Patient in Phase 1/2 GOBLET Study Evaluating Pelareorep-anti-PD-L1 Combination Therapies in Gastrointestinal Cancers
Published: 2021-11-03 (Crawled : 12:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 1.4%
H: 0.49%
C: -1.84%
phase 1 test cancer biotech gastrointestinal iot
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.